Noncurrent long-term debt decreased 30.1%
Noncurrent long-term debt changed -30.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Noncurrent long-term debt changed -30.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory / revenue changed -214 basis points from the comparable as-filed period.
Revenue changed +9.4% from the comparable as-filed period.
Current ratio changed -3.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash / debt changed +5959 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed +19.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Debt / revenue changed -259 basis points from the comparable as-filed period.
Capital expenditure changed -21.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed -81 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +4.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +4.9% from the comparable as-filed period.
Current liabilities changed +7.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash flow / net income changed -25.2% from the comparable as-filed period.
Operating cash-flow margin changed -151 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +1.1% from the comparable as-filed period.
Shares outstanding changed -3.9% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
Reported total debt changed -7.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross debt changed -7.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed +2.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Total assets changed +1.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -70 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / assets changed -40 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +5.5% from the comparable as-filed period.
R&D / revenue changed +19 basis points from the comparable as-filed period.
Revenue changed +9.0% from the comparable as-filed period.
Free-cash-flow margin changed +738 basis points from the comparable as-filed period.
Operating cash-flow margin changed +625 basis points from the comparable as-filed period.
Debt / revenue changed -1293 basis points from the comparable as-filed period.
Debt / assets changed -303 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed -112 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -28.1% from the comparable as-filed period.
Shares outstanding changed -4.6% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Cash & equivalents changed +4.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed +18.3% from the comparable as-filed period.
Current assets changed +4.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed -106 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +7.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed -2.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +37 basis points from the comparable as-filed period.
Selling, general & administrative changed -2.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.